Bipolar Disorder (BPD) Clinical Trials

Find Bipolar Disorder (BPD) Clinical Trials Near You

Study by 1H NMR of the Variations of the Metabolome During the Course of Electroconvulsive Therapy in Patients With Major Depressive Episode

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Investigators will measure the variation of blood Metabolome through 1H NMR at several time points during the course of electroconvulsivetherapy in patients with a major depressive episode. Patients with a major depressive disorder or a bipolar disorder and a current major depressive episode will be included in this study. Investigators hypothesized that Metabolome could be a source to predict response during ECT and to help understanding underlying biological mechanisms.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Major depressive episode according to DSM-5 criteria

• Diagnosis of major depressive disorder or bipolar disorder

• MADRS score \>22

• having given written, free and informed consent

• without protective measures

• resistance criterion defined as failure of 2 antidepressants at an effective dose for a minimum of 6 weeks

• current major depressive episode according to DSM-5 criteria with indication of treatment by ECT cure

Locations
Other Locations
France
Centre Hospitalier le Vinatier
RECRUITING
Bron
Contact Information
Primary
COSTEMALE-LACOSTE Jean-François, PH
jean-francois.costemale-lacoste@ch-le-vinatier.fr
(0)4 37 91 54 95
Backup
SARTELET Lydie
lydie.sartelet@ch-le-vinatier.fr
0437915531
Time Frame
Start Date: 2024-03-11
Estimated Completion Date: 2026-10-15
Participants
Target number of participants: 50
Treatments
Other: Electroconvulsive therapy
simple-blind, any adult patient presenting a characterized depressive episode in the context of unipolar major depressive disorder or bipolar disorder who consents and requires an ECT treatment. study including 50 patients.
Related Therapeutic Areas
Sponsors
Leads: Hôpital le Vinatier

This content was sourced from clinicaltrials.gov